Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.005 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |